Lyser DP Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. This formulation is designed to provide effective relief from mild to moderate pain and inflammation associated with conditions such as musculoskeletal disorders, postoperative pain, dental pain, and soft tissue injuries. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever, enhancing the analgesic effect without causing significant gastrointestinal irritation. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation, contributing to faster recovery. The synergistic action of these three components makes Lyser DP Tablet an effective option for managing acute pain and inflammatory conditions. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, active gastrointestinal bleeding, or severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors. Dosage and duration of therapy must be tailored to individual patient needs to optimize therapeutic outcomes and minimize adverse effects.